Physician profile
Mitchell Meghpara
NPI 1295178465
$34,031.55
in general payments reported to CMS, 2019-2025
20 companies · $1,631 in 2025
The $1,631 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23K · 2020: $2,151 · 2021: $2,744 · 2022: $1,982 · 2023: $1,666 · 2024: $551 · 2025: $1,631.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,953 · Travel and Lodging: $1,896.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,952.56 |
| Travel and Lodging | $1,895.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $19,070.07 | 2019-2025 | |
| Smith+Nephew, INC. | $6,462.51 | 2019-2025 | Bone Anchors With Arthroscopic Delivery System, Tandem, Real Intelligence |
| Stryker Corporation | $3,234.84 | 2019-2025 | Salvation, Samurai, Mako |
| Medwest Associates | $2,460.00 | 2019-2020 | |
| Core Surgical Group | $1,393.44 | 2023-2025 | |
| Medinc of Texas | $445.69 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $261.66 | 2023-2025 | Exparel, Iovera, Zilretta |
| Medacta USA, INC. | $186.37 | 2020-2024 | |
| Miach Orthopaedics, INC. | $170.79 | 2024 | |
| Depuy Synthes Sales INC. | $67.86 | 2021-2023 | Monovisc, Orthovisc |
| Abbott Laboratories | $50.19 | 2023-2024 | Proclaim |
| Djo, LLC | $42.12 | 2021 | |
| Bioventus LLC | $38.27 | 2025 | Xcell |
| Innovation Technologies INC | $28.45 | 2021 | |
| Orthofix Medical, INC. | $26.54 | 2023 | Spinal-Stim, Physio-Stim |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $24.98 | 2021 | |
| Ethicon US, LLC | $24.29 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $15.37 | 2025 | Wainua |
| Ferring Pharmaceuticals INC. | $14.36 | 2024 | Euflexxa |
| Nevro Corp. | $13.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Meghpara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.